smsbiotech logo blue
Home
resources
Science
Science
Explore our proprietary Small Mobile Stem (SMS) cell technology
Animal Studies
Review our pre-clinical proof-of-concept and safety studies
Human Studies
Track our groundbreaking Phase I clinical trial targeting COPD.
Insights
Discover our latest breakthroughs, company news, and milestones
Presentations
Access our scientific posters and conference presentations
company
About us
Learn about our mission to revolutionize regenerative medicine 
Leadership
Meet the team of leading researchers, business executives, and expert advisors
Careers
We're hiring!
We’re always looking for talented people. Join our team!
Investors
Explore investment opportunities and learn about our proprietary technology
Newsweek: The New Era of Life Sciences 2025
Newsweek: The New Era of Life Sciences 2025
Read
pipeline
contact
smsbiotech logo blue
Home
resources
Science
Science

Explore our proprietary Small Mobile Stem (SMS) cell technology

Animal Studies

Review our pre-clinical proof-of-concept and safety studies

Human Studies

Track our groundbreaking Phase I clinical trial targeting COPD.

Insights

Discover our latest breakthroughs, company news, and milestones

Presentations

Access our scientific posters and conference presentations

Company
About us

Learn about our mission to revolutionize regenerative medicine 

Leadership

Meet the team of leading researchers, business executives, and expert advisors

Careers
We're hiring!

We’re always looking for talented people. Join our team!

Investors

Explore investment opportunities and learn about our proprietary technology

pipeline
Contact Us

Insights

The latest of our scientific presentations in the field of stem cell research and treatment.

All
Scientific Poster
COPD
Interview
Insights
Company News
Science
Presentations
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
SMSbiotech Establishes a CRADA with the U.S. Army Medical Research Institute of Chemical Defense
Company News
Insights

SMSbiotech Establishes a CRADA with the U.S. Army Medical Research Institute of Chemical Defense

April 22, 2025
SMSbiotech Receives Green Light for Phase I Clinical Trial in Australia, Targeting COPD
Company News
Insights

SMSbiotech Receives Green Light for Phase I Clinical Trial in Australia, Targeting COPD

SMSbiotech has secured approval to commence a Phase I clinical trial for COPD in Australia.

March 18, 2025
Unveiling Hope: A Potential Breakthrough Treatment for COPD from SMSbiotech
COPD
Insights

Unveiling Hope: A Potential Breakthrough Treatment for COPD from SMSbiotech

Understanding COPD and our revolutionary approach to treatment

December 8, 2023
SMS biotech logo
Regenerative Medicine Enabled by a Novel Stem Cell Technology
Science
The ScienceAnimal StudiesHuman StudiesInsightsPresentations
Company
About UsLeadershipInvestorsCareers
Pipeline
Overview
Contact Us
ContactTerms & Conditions of SalesTerms of Use
© 2023 SMSbiotech All rights reserved.